Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Rafarma Pharmaceuticals, Inc.    RAFA

RAFARMA PHARMACEUTICALS, INC.

(RAFA)
SummaryQuotesChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Rafarma Pharmaceuticals : Establishes Thailand Corporate Entity For Merger and Expansion Projects

08/25/2020 | 11:13am EST

Ljubljana, Slovenia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is pleased to announce that it has established a new corporate entity in Thailand. The entity is registered under the name of RAFARMA (THAILAND) CO., LTD. The Company intends to use the business entity for entering into new association agreements with Thai universities. New association agreements are currently under negotiations and are expected to cover research and joint projects in production of cannabis based products. Also, in the light of recent agreement with R. & D. BIOCOGENCY LABORATORIES GROUP, the Company will use the new entity to conduct clinical trials and license its new products in Thailand for future distribution in South-East Asian markets.

For more information, contact:

RAFARMA
(307) 429-2029


LOGO.png

Source: RAFARMA PHARMACEUTICALS INC

2020 GlobeNewswire, Inc., source Press Releases

All news about RAFARMA PHARMACEUTICALS, INC.
2020Rafarma Merger Company Bebig Approved For Production And Sale Of Yttrium-90 F..
GL
2020Rafarma Inks Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia
GL
2020RAFARMA PHARMACEUTICALS : Letter To Shareholders from Chairman Ilya Shpurov
AQ
2020Letter To Shareholders from Chairman Ilya Shpurov
GL
2020RAFARMA PHARMACEUTICALS : Auditing Firm L J Soldinger Associates Retained for Ra..
AQ
2020Auditing Firm L J Soldinger Associates Retained for Rafarma Biocogency Merger
GL
2020RAFARMA PHARMACEUTICALS : Closes Biocogency Merger
AQ
2020Rafarma Closes Biocogency Merger
GL
2020RAFARMA PHARMACEUTICALS : Approves Issuance of Majority of Voting Shares to Boar..
AQ
2020Rafarma Approves Issuance of Majority of Voting Shares to Board Chairman Ilya..
GL
More news
Chart RAFARMA PHARMACEUTICALS, INC.
Duration : Period :
Rafarma Pharmaceuticals, Inc. Technical Analysis Chart | RAFA | US75062C1009 | MarketScreener
Managers and Directors
NameTitle
Vladimir G. Dolgolenko President & Chief Executive Officer
Ilya Shpurov Chairman